Topics

Articles

A Day 3 presentation dives into the impact of copay accumulators, maximizers, and AFPs on driving cost savings. 

Hubs East 2025: The Patient Access Landscape

The session provides an overview of the uninsured population, and also tackles challenges faced by patients when it comes to accessing PAPs.

PAP 2025: Understanding the Uninsured Landscape

This link in the pharma supply chain is undergoing a major transformation propelled by technological advancements, regulatory changes, and evolving market dynamics, requiring industry leaders to adopt innovative strategies in order to remain competitive.

Strategic Trends in Pharmaceutical Manufacturing for Industry Leaders

Videos

In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Brad Stewart, BDO’s national life sciences co-leader, discusses how the tariffs impact the reshoring of manufacturing services, alongside the strategies that pharma leaders can use in order to start shoring up their supply chains.

The Case for Reshoring Manufacturing to the United States

In the final part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Geoffrey Joyce, PhD, director of health policy at the Leonard D. Schaeffer Center for Health Policy & Economics at USC, describes how PBMs financially benefit from generics, and why a completely open generic market powered by cash would be beneficial. 

How a Completely Open Generic Market Could Alter Rx Costs

In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Geoffrey Joyce, PhD, director of health policy at the Leonard D. Schaeffer Center for Health Policy & Economics at USC, outlines how the tax on goods coming from China and potential 25% tariff on pharmaceuticals could influence generic drug prices. 

Impact of Tariffs on the Generic Drug Market

In the first part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Jenna Dale, director of client relations at Cencora, shares how the imposed/pending trade tariffs impact pharma manufacturers.

Properly Preparing for Tariffs and Other Supply Chain Obstacles

A founding partner with Curatio Scientia Advisors.

A founding partner with Curatio Scientia Advisor.

A report offers a comprehensive benchmarking and assessment of pharmaceutical manufacturer engagement with specialty pharmacies.

Transforming Specialty Pharmacy Engagement

In the final part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Ed Schoonveld value & access advisor for Schoonveld Advisory and author of The Price of Global Health, previews his upcoming February column.

The Rundown on Rebates

In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Ed Schoonveld, value & access advisor for Schoonveld Advisory and author of The Price of Global Health, comments on the future implications of the latest CMS drug price negotiations.

Opinion